SyntheX's Incubator/Accelerator - II Round

SyntheX raised a round of funding on April 27, 2017. Investors include JLabs.

SyntheX aims to expand drug design for the treatment of cancer and rare diseases by implementing a platform for the discovery of new classes of therapeutics that target the weakness in cancer cells (s…

Articles about SyntheX's Incubator/Accelerator - II Round: